key: cord-0789993-5zvu5vnx
authors: Markar, Sheraz R.; Martin, Guy; Penna, Marta; Yalamanchili, Seema; Beatty, Jasmine Winter; Clarke, Jonathan; Erridge, Simon; Sounderajah, Viknesh; Denning, Max; Scott, Alasdair; Purkayastha, Sanjay; Kinross, James
title: Changing the Paradigm of Surgical Research During a Pandemic
date: 2020-05-01
journal: Ann Surg
DOI: 10.1097/sla.0000000000004000
sha: a0459978d89c629b33b480c7f92ac59d1fd964e3
doc_id: 789993
cord_uid: 5zvu5vnx

nan

The traditional model for surgical research typically involves generating incremental improvements in clinical outcomes either through the optimization of existing approaches, or through the introduction of novel techniques. This process is often painstakingly slow 1 with a significant time lag from the initial development of an idea, through to the delivery of a highly controlled trial and subsequent clinical translation. [2] [3] [4] In many instances, this resource consuming process may not produce an agreed conclusion nor be widely adopted within routine practice. Surgical research is absolutely necessary during a pandemic to guide surgical treatment during the pandemic, to prepare surgical services for what is to come after the pandemic, and the next stages of healthcare recovery.

The current COVID-19 pandemic 5, 6 has demonstrated that the existing paradigm of surgical research, predominantly reliant upon incremental innovation, is not fit for this purpose. As such, in order to prevent avoidable harm, we must now urgently adapt from a rigid system of highly controlled prospective trials, towards an adaptive and pragmatic approach, which is focused upon delivering agile evidence-based changes in practice at pace and scale. In order to achieve this, we must be cognizant of the specific challenges that lie ahead as well as the strategies that we must champion so that we may overcome them.

Global crises such as COVID-19, exert intolerable stress on the delivery of clinical research, which is typically compromised as clinical scientists are redirected to the front line. This Research in a time of crisis must also address system wide challenges. Firstly, like any other service it requires effective leadership with a command and control structure. This has been strikingly absent, and it is now critical that global funding bodies and our professional associations pick up the ball and take the initiative. 7 We urgently require clear priorities and networks around which clinical research can be coordinated.

Time remains a significant limiting factor in this pandemic, particularly because of the speed of transmission which has caught many governments and healthcare providers off guard. 8 As a result, critical functions of research, such as ethical approvals, must be acquired under immense pressure. This process is further compounded by limited capacity within research infrastructures to adapt to staff becoming unwell or the loss of administrative staff. Similarly, clinical academics will face increasing demands in service provision leaving limited bandwidth to dedicate to research. Some of these challenges are predictable, but many are not, and a global crisis of this magnitude means that both research networks and systems may be unreliable, and patient responses to both established and new surgical interventions may vary dramatically. Therefore, confounders may strongly influence outcomes seen during a pandemic.

However, during a crisis many barriers to research also come down, facilitating widespread collaboration within and between units on an international scale. During the COVID-19 pandemic, there is evidence of trials in medical therapies, 9 prevention strategies 10 and vaccines. 11 Surgeons now urgently require the same approach if we are to optimise the treatment of surgical pathology and protect our staff. But, even during times of crises balance between rapid dissemination and robust scientific methodology is required if robust work of Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.

impact is to be produced. Moreover, it must be communicated and synthesised at pace. Many journals, including Annals of Surgery, have changed their publication process to facilitate learning and create new models of content distribution. Teams are finding new ways of working through digital platforms and social networks, and there has never been more data and computing power available to clinicians who have to solve some of our biggest problems.

During a pandemic the ethos of surgical research must change. The traditional model of scientific investigation and peer-reviewed publication must swiftly adapt to the fast moving pace of the disease, aiming to achieve greater understanding with quality improvement measures, rapid dissemination and clinical implementation to maximize the quality of care we deliver to our patients. Not doing so risks the propagation of falsehoods and non-evidence based practice.

A new tailored approach to surgical research that aims to address the pandemic crisis should include four key principles.

Firstly, collaborative learning is essential to the success of any surgical project. New digital technologies with a national, and more importantly, a global reach can serve as incredibly useful forums for discussion and shared learning across countries and health systems as they Thirdly, it is vital to remember that data is key to surgical research during a pandemic. Data capture must be focused to limit collection and entry fatigue, but also robust enough to permit meaningful analysis. Focused analytics during pandemics may include the generation of novel dynamic risk prediction models 13 ; these can serve to guide clinical decision making and the allocation of limited resources such as choice of intervention and intensive care unit bed utilisation. The modeling of risk during a pandemic is challenging for two important reasons;

(i) the disease itself may change the risk associated with surgical intervention (often increasing risk), and (ii) healthcare resources will be stretched beyond any previous situation and thus cannot be modeled from historical data. Importantly, processes for the review and Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.

approval of such data collection and analysis must also adapt to ensure that vital data and time is not lost.

The fourth principle involves engagement with industry; this is one of the major strengths of technology-focused surgical research and may provide a common model upon which to base new relationships. During a pandemic the traditional funding model is not fit for purpose; the process of applying for a research grant, gaining funding and implementing a project is far too time consuming. Transparent engagement with industry will allow shared learning and pooling of resource, the introduction of new expertise and the rapid delivery of additional funding to support surgical research and new initiatives in a dynamic way.

The rapidly evolving and progressing nature of the present COVID-19 pandemic has highlighted several critical limitations in the traditional model of surgical research; namely, the inability to provide timely evidence to rapidly inform and change clinical practice, thus ultimately defeating its main purpose of improving patient outcomes. The key question remains the same; 'how do we deliver the best possible care for our patients?' What has changed however is that the novel context of a rapidly evolving pandemic which necessitates speed in dissemination and clinical implementation. The traditional approach to surgical research must evolve to cater for (1) iterative learning, (2) novel dissemination methods, (3) rapid data generation and (4) industry collaboration in order to meet the current pandemic challenge.

Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.

The answer is 17 years, what is the question: Understanding time lags in translational research

IDEAL framework for surgical innovation 1: the idea and development stages

IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages

IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage

COVID-19: towards controlling of a pandemic

Defining the epidemiology of Covid-19 -Studies Needed

COVID-19: A global transplant perspective on successfully navigating a pandemic

COVID-19 pandemic: perspectives on an unfolding crisis

Hydroxuchloroquine and azithromycin as a treatment for COVID-19: results of an open-label non-randomized clinical trial

Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts

Clinical trial analysis of 2019-nCoV therapy registered in China

PanSurg Collaborative -PREDICT study Available from

Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited